Viewing Study NCT01999868


Ignite Creation Date: 2025-12-24 @ 5:40 PM
Ignite Modification Date: 2026-02-21 @ 1:36 AM
Study NCT ID: NCT01999868
Status: COMPLETED
Last Update Posted: 2019-01-15
First Post: 2013-11-26
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Efficacy of Ustekinumab Followed by Abatacept for the Treatment of Psoriasis Vulgaris
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Psoriasis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None psoriasis vulgaris View
None ustekinumab View
None abatacept View